Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Johnson & Johnson, Imerys ordered by court to pay at least US$37mln in asbestos suit

Investment banker claimed asbestos in talc product caused cancer

Johnson & Johnson (NYSE:JNJ) and talc-mining company Imerys SA (NK:PA) were ordered to pay at least US$37mln to an investment banker who claimed their talc-based products caused him to develop a deadly cancer, Bloomberg News reported.

Jurors at a state court in New Brunswick, New Jersey, found that the two companies hid that their products, which include J&J’s iconic Baby Powder, were tainted by asbestos, the report said yesterday. In the suit, Stephen Lanzo alleged he developed mesothelioma, a type of cancer, after using the powder for more than 30 years, Bloomberg said.

The jurors found that J&J is liable for 70% of the damages, with Imerys responsible for the rest, according the report.

J&J shares fell US3% to $126.78 at 3:10 p.m. Imerys, a French producer of industrial minerals, dropped 1.8% in Paris.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK